BMF-650 Phase 1 Clinical Trial Results: Critical Early Data
BMF-650 Phase 1 clinical trial results: 1.5% to 3.2% weight loss in outpatient cohorts; a 6.1% cohort had similar placebo loss. Early, unapproved.
BMF-650 Phase 1 clinical trial results: 1.5% to 3.2% weight loss in outpatient cohorts; a 6.1% cohort had similar placebo loss. Early, unapproved.